Next Article in Journal
Analysis of COVID-19 Incidence and Protective Potential of Persisting IgG Class Antibodies against SARS-CoV-2 Infection in Hospital Staff in Poland
Previous Article in Journal
Booster Immunization Improves Memory B Cell Responses in Older Adults Unresponsive to Primary SARS-CoV-2 Immunization
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Knowledge, Attitude, and Practice towards Influenza Vaccination among Older Adults in Southern China during the COVID-19 Pandemic

1
School of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen 518055, China
2
Shenzhen Center for Disease Prevention and Control, Shenzhen 518055, China
*
Authors to whom correspondence should be addressed.
Vaccines 2023, 11(7), 1197; https://doi.org/10.3390/vaccines11071197
Submission received: 23 May 2023 / Revised: 26 June 2023 / Accepted: 27 June 2023 / Published: 4 July 2023

Abstract

:
Influenza is prevalent globally, leading to severe morbidity and mortality. During the pandemic, knowledge, attitude, and practice (KAP) towards influenza virus and vaccination were less investigated among southern Chinese older adults. A cross-sectional study was conducted through the structured questionnaire among community healthcare centers in selected districts in Shenzhen, southern China from September to October 2021. KAP towards influenza virus and vaccination were analyzed. A multivariable logistic regression model was used to identify associated factors. Among 975 participants, 55.6% were reported to have received influenza vaccination ever, and 46.6% had taken influenza vaccination in 2020 during the pandemic. Only one-fifth of participants knew severe comorbidities happen among severe influenza cases. A total of 88.3% thought older adults should have influenza vaccination. COVID-19 vaccination history was associated with receiving influenza vaccination (OR 1.92, 95% CI 1.32–2.80). People with a high-level income had better KAP towards influenza virus and vaccination. COVID-19 vaccination history was associated with the positive actions of influenza vaccination during the pandemic. Efforts should be made to promote the free influenza vaccination program widely and launch health education events on influenza and its vaccination regularly to improve KAP among older adults.

1. Introduction

Influenza is prevalent globally, leading to severe morbidity and mortality [1,2]. It is estimated that worldwide influenza causes approximately 3 to 5 million cases of severe illness and up to 650,000 respiratory deaths every year [2]. Older adults and people with chronic physical conditions are deemed to be at an increased risk of infection and hospitalization due to influenza [2]. In China, it was estimated that roughly 80% of the excess respiratory deaths attributed to influenza were among people aged 60 years or above between 2010 and 2015 [1,3]. With the evolution of the circulating influenza virus, annual vaccination is recommended as the most effective tool to protect against influenza, as immunity is not lifelong [4,5]. WHO recommends the composition of the trivalent vaccine that targets the three most representative virus types in circulation (two subtypes of influenza A viruses and one influenza B virus) [2]. Hence, launching the influenza vaccination program among older adults is a significant approach to alleviating the influenza disease burden.
With the implementation of national medical reform in China in 2009, vaccination services were provided through community health centers (CHCs), including vaccines for influenza, hepatitis B, human papillomavirus, COVID-19, etc. [6,7]. People of all ages can have influenza vaccine uptakes with their out-of-pocket money of 11 to 49 US dollars (76–334 Chinese Yuan) yearly at widely distributed CHCs in urban areas. During the COVID-19 period, since March 2021, the Chinese government has started to offer the COVID-19 vaccine to older adults for free after domestically comprehensive assessments of health status and infection risks [8]. Although the State Council encouraged local governments to offer free vaccination services to highly-risky populations, including healthcare professionals, children aged between 6 months and 5 years, people with chronic diseases, and others who take care of vulnerable populations, free influenza vaccination services were limited and provided only for older adults in some developed Chinese provinces and cities, for example, Zhejiang Province, Beijing, Guangzhou, as well as our study site, Shenzhen City [9]. Despite many conveniences, compared with influenza vaccination coverage in developed countries, 82.3% in England, 90.2% in Scotland, 75.2% in the United States, 55.0% in Russia, and 56.8% in France during the 2022 flu season, in China, according to previous research, it remained low (4–13%) among older adults [10,11,12,13].
Previous studies focused on the knowledge, attitude, and practice (KAP) of healthcare professionals, pregnant women, travelers, and general workers towards influenza virus and vaccination in different countries and regions [14,15,16,17]. A satisfactory level of knowledge related to COVID-19 and its prevention among the Italian elderly was found [18], which promised a positive attitude and practice towards vaccination. Evidence showed that vaccination-prioritized populations including older adults having insufficient knowledge were associated with low vaccination coverage [19], which indicated that lack of knowledge had an impact on their attitude and practice of vaccination. However, related evidence on the KAP of vaccination is quite limited in China. For example, one study focusing on older adults aged 60 years and above in eastern China was conducted in 2015 to describe early and regional KAP results related to influenza and its vaccination [12]. Less is known about KAP towards influenza virus and vaccination among older adults in southern China during the COVID-19 period with the appearance of free vaccination services.
This study aimed to investigate KAP towards influenza virus and vaccination among 975 Chinese older adults aged 60 years and above and identify associated influenza-related factors with their actions of vaccination. In addition, our study would provide valuable insight into the potential target population and suggest corresponding measures to improve vaccination coverage more efficiently, which is beneficial to promote vaccination-related policy.

2. Materials and Methods

2.1. Study Design and Participants

From 24 September to 20 October 2021, a cross-sectional survey was conducted on the demographic and socioeconomic information, disease and vaccination history, and KAP regarding influenza virus and vaccination in Shenzhen, China. Shenzhen is located in southern China, being one of the first-tier cities with more than 17 million residents. There are 10 districts with more than 700 community health centers in Shenzhen. Ten CHCs in two large districts (Nanshan and Guangming) of Shenzhen were randomly selected as our study sites.
Participants were included through convenient sampling in our study if they (1) were aged 60 years old and above before September 2021; (2) attended the above-included CHCs; and (3) were willing to complete the questionnaire. Considering the feasibility of the study design and the strong mobility of the population in the mega city of Shenzhen, as many participants were included as possible. Overall, 993 older adults were enrolled in our study. Of them, 975 participants had complete information and were valid for data analyses. A total of 18 participants were excluded because they did not state their influenza vaccination status, which was conducted as our primary outcome.

2.2. Data Collection

Trained interviewers administered the structured questionnaire to included participants, asked questions from the questionnaire to each participant, and wrote down the answers in person. Before this questionnaire was made available to all participants, a pilot study was conducted on a small sample of older participants (N = 30) to ensure that the questionnaire was easily understandable and completed. The structured questionnaire consisted of detailed questions on demographic and socioeconomic characteristics, health conditions, KAP on influenza and its vaccination, as well as health education on vaccination.
Demographic and socioeconomic characteristics were measured by sex (female and male), age (60–64, 65–75, and above 75 years old), education level (primary school and below, middle and high school, and college and above), marital status (unmarried and married), and monthly income (1000 and below Chinese Yuan (CNY), 1001–5000, and 5001 and above). Health conditions were assessed by self-awareness of health status (well, general, and worse), chronic disease history (yes and no), and COVID-19 vaccination history (yes and no).
The KAP questionnaire was a part of the structured questionnaire, including knowledge, attitude, and practice towards influenza virus and vaccine. The knowledge survey included influenza virus and vaccine items that were measured by influenza symptoms, prevention measures, vaccination-prioritized populations, vaccination frequencies, vaccination season, vaccine protection duration, the places to get vaccinated, and if they ever knew about influenza vaccine and vaccination policy. The attitude survey included opinions on whether older people and people with chronic diseases should have influenza vaccine uptake and thoughts about vaccination education. The practice survey included cues to actions, vaccine actions, and reasons for being unwilling to receive influenza vaccines. Cues to action consisted of recommendations from healthcare workers, previous vaccination awareness of people around, and participation in vaccine education programs. Actions included self-reported influenza vaccination history before the interview time and in the specific 2020 influenza season. Participants being stratified by influenza vaccination history at that time were categorized as vaccinated status and unvaccinated status as our primary outcome. In addition, participants stratified by influenza vaccination history in the 2020 influenza season were categorized as vaccinated status and unvaccinated status in 2020.

2.3. Statistical Analysis

Statistical analysis was performed with Stata version 17 (StataCorp Inc., Chicago, IL, USA). All categorical variables were described with frequencies (N) and percentages (%). Frequencies and proportions were used to describe the detailed information on knowledge of the influenza virus and vaccine (9 survey items), attitude towards influenza vaccination and its education program (3 survey items), and practice of influenza vaccination (6 survey items). The Chi-square test was used to evaluate the differences in knowledge, attitude, and practice towards influenza virus and vaccination between subgroups, with analyses stratified by age groups, education levels, and income levels. Statistically significant survey items among age groups, education levels, and income levels were included in the following multivariable logistic regression model to identify influenza-associated factors. Demographic and socioeconomic factors stratified by previous actions of influenza vaccine with a p value < 0.05 in the Chi-square test were further included in the same multivariable logistic regression model, where fully adjusted odds ratios (ORs) and their corresponding 95% CI were calculated after controlling for other covariates and associated factors.
Subgroup analysis was conducted among participants who reported as vaccinated in 2020. Statistically significant survey items among age groups, education levels, and income levels were included in the following multivariable logistic regression model to identify influenza-associated factors. Demographic factors stratified by ever received actions of influenza vaccine in 2020 with a p value < 0.05 in the Chi-square test were further included in the same multivariable logistic regression model, where ORs and 95% CIs were calculated. A two-sided p < 0.05 was considered statistically significant in multivariate analyses.

2.4. Ethical Statement

Our study was approved by the Shenzhen Center for Disease Control and Prevention. Oral informed consent was obtained from each participant before interviewers administered and distributed the structured questionnaire.

3. Results

3.1. Characteristics of Participants

A total of 975 older participants were included in this analysis. In Table 1, it can be seen that more females (56.3%) than males (43.7%) were involved in this analysis. The mean age of participants was 69.4 years old, with a standard deviation of 6.4 years old, and 575 (59%) were between 65 and 75 years old. In total, 823 (87.4%) were married and more than half of the participants had middle and high school diplomas, followed by primary school and below. Overall, 429 (44.0%) had middle-income levels of 1000 to 5000 Chinese yuan (CNY), 592 (60.7%) considered their health well and 441 were diagnosed with chronic medical conditions by a doctor before, and 813 (83.4%) had received COVID-19 vaccine uptakes since the breakout of COVID-19 at the beginning of 2020.

3.2. Knowledge of Influenza Virus and Vaccination

In Table 2, only one-fifth of participants (N = 214) knew severe comorbidities would happen among severe cases affected by the influenza virus. Most participants knew about vaccination as the approach to protecting against influenza. In total, 75.6% thought people aged 60 years old and above, children aged 6 months to 5 years old, and patients with chronic conditions were the prioritized populations to take influenza vaccine uptakes, but only 13.1% knew that women who were pregnant or planned to become pregnant during flu season should take influenza vaccination. Overall, 64.2% participants knew the influenza vaccination frequency (once a year), 58.4% knew the influenza vaccination time frame (in autumn and winter), 58.4% knew the protection duration (six to eight months), and 74.1% knew the places to take influenza vaccination. Over 70% of participants have heard about influenza vaccination and knew about the free influenza vaccination program in Shenzhen.
Most older people knew about vaccination as the method to prevent the influenza virus, the protection duration of influenza vaccine, and the places to take vaccination (p < 0.05 in three survey items in Table 3). Compared with participants with primary school or above education, participants with higher education levels had better knowledge of influenza symptoms, prioritized populations, vaccination frequency, places, protection duration, as well as vaccination policy (p < 0.05 for most survey items in Table 3). So did people who have higher monthly income (p < 0.05 for most survey items). The differences in vaccine protection duration and places existed in each age group, educational level, and income level (p < 0.05 in three subgroups).

3.3. Attitude towards Influenza Vaccination and Education Program

In Table 4, 861 (88.3%) participants thought older adults should take influenza vaccination and over half considered that older adults with chronic medical conditions were bound to take the vaccination. A total of 652 (65.9%) thought it beneficial to participate in the vaccination education program.
Most participants (58.9%) between 65 and 74 years old thought older adults diagnosed with chronic conditions should take influenza vaccination compared with the other two age groups (20.9% vs. 58.9% vs. 20.2%, p = 0.010 in Table 5). People with middle and high school education or middle level of income had a more positive attitude towards influenza vaccination and education programs, showing more agreement in three survey items (p < 0.05 in Table 5). The differences in attitudes towards vaccination among older adults with chronic diseases existed in each age group, educational level, and income level (p < 0.05 in three subgroups).

3.4. Practices of Influenza Vaccination

In Table 6, cues to actions of influenza vaccination included three items as follows: 653 (67.0%) participants were recommended the influenza vaccination by healthcare workers, but 542 (55.6%) reported to have received influenza vaccination and 454 (46.6%) have taken influenza vaccine uptakes in 2020 during the COVID-19 period. Around 60% of participants heard about people around who have taken influenza uptakes. One-third of participants have ever taken part in health education programs. In Table 7, additionally, the associations of vaccinated people around previous vaccination status and vaccination status in 2020 differed by age, education, and income levels (p < 0.05). Participants among 65 to 74 years old, holding middle and high school diplomas, or with higher income levels, were reported to have received influenza vaccination and taken influenza vaccine uptakes in 2020 (p < 0.05).

3.5. Reasons for Being Unwilling to Receive the Influenza Vaccines

Among 433 participants who reported not receiving influenza vaccination before, their reasons for being not vaccinated are presented in Table 6. The top three reasons were as follows: participants reported that they did not know about influenza vaccination (43.0%); they thought they stayed in good conditions and there was no need to take the influenza vaccine (27.5%); and they had no time to take the influenza vaccine (12.5%). It is worth noticing that only 2.8% of participants thought the influenza vaccine had no effect. Only 24 (5.5%) participants did not have the influenza vaccine because physicians have not ever recommended it, and another 23 (5.3%) considered it too much cost.

3.6. Multivariate Analysis

Using the actions of influenza vaccination as the primary outcome, a multivariate analysis was conducted to determine what variables were associated with our primary outcome. The differences in influenza vaccination status existed in knowledge items of influenza vaccination protective duration, the places to have influenza uptakes, and attitudes towards whether older adults with chronic conditions should take influenza vaccination. In Table 8, compared with younger participants less than 65 years old, participants aged above 65 years old were at higher odds of being vaccinated, with the odds ratio of 1.46 (95% CI 1.02–2.10) for the 65–75 age group and the odds ratio of 1.81 (95% CI 1.10–2.98) for the above 75 age group. Marital status and education levels were not associated with influenza vaccinated status after adjusting for other significant influenza-associated factors. Participants who had a high-level monthly income were associated with higher odds of being vaccinated (5001 and above CNY: OR 2.64, 95% CI 1.66–4.18). COVID-19 vaccination history was not statistically significantly associated with our primary outcome of previous vaccination status before the year 2020. Participants who answered correctly on vaccination protection duration were associated with having influenza vaccine uptakes (OR 2.76, 95% CI 1.99–3.84). Participants who knew about the places of vaccination were associated with the vaccinated status (OR 5.00, 95% CI 3.42–7.32). Moreover, participants who thought older adults with chronic conditions should take influenza vaccination were associated with having vaccination (OR 2.08, 95% CI 1.51–2.85).

3.7. Subgroup Analysis

In subgroup analysis, another multivariate regression model stratified by the actions of the influenza vaccine in 2020 was conducted. Identified influenza-associated factors were similar to the results stratified by previous actions of influenza vaccination, but during the COVID-19 period, COVID-19 vaccination history was associated with receiving influenza vaccine uptakes (OR 1.57, 95% CI 1.05–2.37). Participants who had a high-level monthly income were associated with higher odds of being vaccinated (5001 and above CNY: OR 1.69, 95% CI 1.10–2.61). Participants who answered correctly on vaccination protection duration were associated with having influenza vaccine uptakes (OR 2.15, 95% CI 1.58–2.93). Participants who knew about the places of vaccination were associated with the vaccinated status (OR 4.22, 95% CI 2.85–6.24). Moreover, participants who thought older adults with chronic conditions should take influenza vaccination were associated with having vaccination (OR 1.73, 95% CI 1.27–2.35).

4. Discussion

A cross-sectional survey was conducted to evaluate the knowledge, attitudes, and practices toward influenza virus and vaccination among 975 Chinese older adults aged 60 years and above and identify influenza vaccination-associated factors from September to October 2021 in southern China. The vaccination coverage was 55.6% among our participants. People with a higher education or income level had a better performance of knowledge, attitude, and practice towards influenza virus and vaccination. People with higher income levels and better knowledge and attitude were associated with the positive actions of influenza vaccination.
As a result of complex and diverse vaccination policies being implemented in different cities in China, the vaccination coverage rate showed differences among older populations, for example, 55.6% in this study, being much higher than those of previous studies among older adults, ranging from 4.3% to 40.0% [20], but lower than that of the US in 2022 [21]. This difference might be attributed to the fact that people living in Shenzhen are provided with fruitful medical resources and health information offerings from the high-quality primary healthcare system supported by the municipal government [22]. Additionally, evidence showed that health literacy was apparently higher among people in Shenzhen compared with the Chinese average level, which referred to the ability and basic diathesis to acquire and use health information and make health-associated associations, for example, vaccination in the present study [23,24]. Statistically significant influenza-associated factors in knowledge and attitude survey items were identified, which showed that people having sufficient and correct knowledge as well as positive attitude towards influenza vaccination were associated with having vaccination. However, four-fifths of participants were not aware of the occurrence of severe comorbidity, which made people look down upon influenza. A large proportion of them did not know pregnant women as one of the risky populations of infection, which potentially poses a threat to pregnant women and their babies. This reflected the knowledge barriers among our participants. Appropriate health education programs are urgently needed among older adults.
Previous studies focused on healthcare professionals, pregnant women, and travelers in different regions with the impact of vaccination policies [14,16,17]. Evidence showed that an appropriate vaccination policy indeed has a positive impact on the coverage rate [25], which indicated that a free vaccination policy might attract more attention. The study site, Shenzhen, as the first-tier city in China, has already provided free influenza vaccination among older permanent residents aged 60 years or above for 7 years. Previous studies also proved a positive influence on influenza vaccination coverage under the launch of free influenza vaccination programs for older adults [26]. Vaccination policy was considered one of the most significant vaccination-related factors [27]. Our study also affirmed this factor, stating that older adults who ever knew about the free vaccination program were associated with having the influenza vaccine uptake. This beneficial policy should be generalized among other capable cities to improve influenza vaccination coverage among older adults.
Almost 90% of participants agreed that older adults should take influenza vaccination, but only half of our participants had influenza vaccine uptakes before. The older participants who were less educated were associated with not having influenza vaccination in this study compared with participants with higher education levels. It is consistent with previous studies, indicating that people with low literacy might ignore written information [28], for example, leaflets and posters on free influenza vaccination in CHCs. However, older participants with higher education or income levels in this study knew more about older adults who had influenza vaccination before. It is possible that they were influenced to have vaccine uptakes by their acquaintances, that is, the acquaintance effect. This factor needs to be explored in vaccination studies further.
The popularity of influenza vaccination was limited to some degree because almost half of the unvaccinated participants reported they did not know about the vaccination program as the top reason. This indicated that the influenza vaccination program should strengthen promotion among the public mass. A small proportion of people considered themselves healthy enough for it to be unnecessary to have influenza uptakes, which was the second reason. This demonstrated the misunderstanding of susceptible populations regarding influenza virus and the necessity of vaccination education programs widely and regularly. Despite the shortages of vaccination programs, a few people thought the influenza vaccine had no effect, which indicated that vaccination education played an important role in improving vaccine-associated knowledge. Several participants mentioned that they were not recommended to have influenza vaccine uptakes by their physicians, but recommending vaccination was supposed to be their work responsibility in our previous studies [26]. This reflected deficiencies in physicians’ work to some degree.
COVID-19 vaccination history was found to be associated with influenza vaccination in 2020, which might be due to their good level of perception on both viruses and their vaccines, being consistent with a cross-sectional study focusing on the knowledge related to COVID-19 among the Italian elderly [18]. During the 2020 flu season with the pandemic, many people perceived the COVID-19 virus as the influenza virus mistakenly because of their similar symptoms, and people were willing to have influenza vaccination when there was no COVID-19 vaccine approved. Our findings suggested that participants with higher education and income levels are associated with having influenza vaccine uptake. Moreover, health and vaccine information on COVID-19 was gradually promoted widely and deeply during the pandemic [29]. The promotion of influenza education cannot reach the point of COVID-19, obviously. Nowadays, with the decreasing cases of COVID-19 daily, the new cases of type A influenza have started to increase and the positive rate is up to 25.1% [30]. Hence, it is urgent to promote influenza and influenza vaccination-related information in China, especially for older adults.
Physicians were reported as a significant factor in multiple studies [15,31]. In our study, similarly, 67% of participants were recommended the influenza vaccination by healthcare workers, and only a few participants stated their un-vaccination status was due to no recommendation from professionals, but half of them were influenza vaccinated. Hence, providing recommendations from professionals is the most convenient and reliable method to improve the influenza vaccination-associated information as well as coverage rate. However, vaccine hesitancy existed among both patients and healthcare professionals. Patients worry about the inefficacy of vaccines and the fear of adverse effects [32]. Professionals may have concerns about the responsibility of medical accidents if an allergy reaction or severe side effects appear after patients’ follow the recommendation of vaccination from them, which needs further investigation as to the reason for not recommending vaccination. Hence, to eliminate vaccine hesitancy, proper and correct vaccination education is needed among healthcare professionals and patients regularly.
Several limitations of this study must be acknowledged. First, recall bias might exist when responding to past experiences. For example, previous vaccination status as our primary outcome was self-reported. Second, considering that the sample was from Shenzhen, where adults aged 60 and above take the proportion of 5.36% (0.95 million), compared with the national average of 18.7% [33,34], our study results might not be generalized to other Chinese cities. Moreover, Shenzhen, as one of four first-tier super cities with the top gross national product in China, is capable of offering financial support for multiple vaccination programs for specific populations. Hence, other governments should tailor their vaccination policy. Third, selection bias might exist, as only participants who visited the included CHCs were included. Fourth, because of the nature of study design, this survey was conducted at the beginning of the influenza season and the attitudes and practices only reflected the information available at a certain point. The actual KAP may have changed after our study period. Future study is needed to assess the KAP towards influenza virus and vaccination among risky populations after the COVID-19 pandemic for further vaccination policy making.

5. Conclusions

In conclusion, our study provided valuable insights into the free influenza vaccination policy, which played a significant role in improving vaccination coverage. A relatively high vaccination coverage was found among older adults in Shenzhen. People with higher income levels had a better performance of knowledge, attitude, and practice towards influenza virus and vaccination. COVID-19 vaccination history was associated with the actions of influenza vaccination during the pandemic. Therefore, more actions from the government should be taken to improve influenza vaccination coverage among older adults through providing health education regularly to improve knowledge and attitudes and delivering wide promotion of the free influenza vaccination program to facilitate older adults’ practices.

Author Contributions

Conceptualization, X.H. and G.L.; Methodology, X.H.; Software, Y.Y.; Formal Analysis, Y.Y.; Investigation, G.L. and X.L.; Resources, X.Z. and G.L.; Data Curation, G.L.; Writing—Original Draft Preparation, Y.Y.; Writing—Review and Editing, Y.Y., X.L., B.C., G.L. and X.H.; Supervision, X.H.; Project Administration, X.H. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The survey study was reviewed and approved by the Institutional Review Board of Shenzhen Center for Disease Prevention and Control.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data will be made available on request.

Acknowledgments

We would like to thank all involved participants and physicians in each community healthcare center and Shenzhen Center for Disease Control and Prevention for their contribution to this study.

Conflicts of Interest

The authors declare that they have no known competing financial interest or personal relationship that could have appeared to influence the work reported in this paper.

References

  1. Li, L.; Liu, Y.; Wu, P.; Peng, Z.; Wang, X.; Chen, T.; Wong, J.Y.T.; Yang, J.; Bond, H.S.; Wang, L.; et al. Influenza-associated excess respiratory mortality in China, 2010–2015: A population-based study. Lancet Public Health 2019, 4, e473–e481. [Google Scholar] [CrossRef] [PubMed]
  2. WHO. Influenza (Seasonal). Available online: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal) (accessed on 19 January 2023).
  3. Feng, L.; Shay, D.K.; Jiang, Y.; Zhou, H.; Chen, X.; Zheng, Y.; Jiang, L.; Zhang, Q.; Lin, H.; Wang, S.; et al. Influenza-associated mortality in temperate and subtropical Chinese cities, 2003–2008. Bull. World Health Organ. 2012, 90, 279–288b. [Google Scholar] [CrossRef] [PubMed]
  4. Chinese Center for Disease Control and Prevention. Technical Guidelines for Influenza Vaccination in China (2022–2023). Available online: https://www.chinacdc.cn/yyrdgz/202208/t20220825_260956.html (accessed on 21 February 2023).
  5. Petrova, V.N.; Russell, C.A. The evolution of seasonal influenza viruses. Nat. Rev. Microbiol. 2018, 16, 47–60. [Google Scholar] [CrossRef] [PubMed]
  6. General Office of the State Council. The General Office of the State Council on the Distribution of the Medical and Health System-Notice of the Work Schedule for 2009 on Five Key Reforms. Available online: https://www.gov.cn/zwgk/2009-07/23/content_1372946.htm (accessed on 6 March 2023).
  7. Government of China. The COVID-19 Vaccine Is Free for All and the Health Insurance Fund and the Treasury Share the Burden. Available online: http://www.gov.cn/fuwu/2021-01/09/content_5578430.htm (accessed on 6 March 2023).
  8. NHC—National Health Commission: The Elderly over 60 Years Old Will Start Large-Scale Vaccination of the New Crown Vaccine. Available online: https://www.gov.cn/xinwen/2021-03/22/content_5594346.htm (accessed on 14 June 2023).
  9. Government of China. Focus on the Notice on Influenza Prevention and Control in the 2021–2022 Epidemic Season. Available online: http://www.gov.cn/xinwen/2021-10/18/content_5643354.htm (accessed on 16 May 2023).
  10. Center for Disease Control and Prevention. Flu Vaccination Coverage, United States, 2020–2021 Influenza Season. Available online: https://www.cdc.gov/flu/fluvaxview/coverage-2021estimates.htm (accessed on 19 January 2023).
  11. UK Government. Surveillance of Influenza and Other Seasonal Respiratory Viruses in Winter 2021 to 2022. Available online: https://www.gov.uk/government/statistics/annual-flu-reports/surveillance-of-influenza-and-other-seasonal-respiratory-viruses-in-winter-2021-to-2022#vaccination (accessed on 19 January 2023).
  12. Wendlandt, R.; Cowling, B.J.; Chen, Y.; Havers, F.; Shifflett, P.; Song, Y.; Zhang, R.; Iuliano, D.; Xu, C.; Yu, H.; et al. Knowledge, attitudes and practices related to the influenza virus and vaccine among older adults in Eastern China. Vaccine 2018, 36, 2673–2682. [Google Scholar] [CrossRef] [PubMed]
  13. WHO. Influenza Vaccination Coverage. Available online: https://immunizationdata.who.int/pages/coverage/flu.html?CODE=FRA&ANTIGEN=FLU_ELDERLY&YEAR= (accessed on 13 June 2023).
  14. Erazo, C.E.; Erazo, C.V.; Grijalva, M.J.; Moncayo, A.L. Knowledge, attitudes and practices on influenza vaccination during pregnancy in Quito, Ecuador. BMC Public Health 2021, 21, 72. [Google Scholar] [CrossRef] [PubMed]
  15. Ma, Y.; Li, T.; Chen, W.; Chen, J.; Li, M.; Yang, Z. Knowledge, Attitudes and Practices (KAP) toward seasonal influenza vaccine among young workers in South China. Hum. Vaccines Immunother. 2018, 14, 1283–1293. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Madewell, Z.; Chacón-Fuentes, R.; Badilla-Vargas, X.; Ramirez, C.; Ortiz, M.-R.; Alvis-Estrada, J.-P.; Jara, J. Knowledge, attitudes, and practices for the use of seasonal influenza vaccination, healthcare workers, Costa Rica. J. Infect. Dev. Ctries. 2021, 15, 1004–1013. [Google Scholar] [CrossRef] [PubMed]
  17. Pfeil, A.; Mütsch, M.; Hatz, C.; Szucs, T.D. A cross-sectional survey to evaluate knowledge, attitudes and practices (KAP) regarding seasonal influenza vaccination among European travellers to resource-limited destinations. BMC Public Health 2010, 10, 402. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Gallè, F.; Sabella, E.A.; Roma, P.; Ferracuti, S.; Da Molin, G.; Diella, G.; Montagna, M.T.; Orsi, G.B.; Liguori, G.; Napoli, C. Knowledge and Lifestyle Behaviors Related to COVID-19 Pandemic in People over 65 Years Old from Southern Italy. Int. J. Environ. Res. Public Health 2021, 18, 872. [Google Scholar] [CrossRef] [PubMed]
  19. Blank, P.R.; Schwenkglenks, M.; Szucs, T.D. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J. Infect. 2009, 58, 446–458. [Google Scholar] [CrossRef] [PubMed]
  20. Wang, Q.; Yue, N.; Zheng, M.; Wang, D.; Duan, C.; Yu, X.; Zhang, X.; Bao, C.; Jin, H. Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: A meta-analysis. Vaccine 2018, 36, 7262–7269. [Google Scholar] [CrossRef] [PubMed]
  21. Center for Disease Control and Prevention. Flu Vaccination Coverage, United States, 2021–2022 Influenza Season. Available online: https://www.cdc.gov/flu/fluvaxview/coverage-2022estimates.htm (accessed on 19 January 2023).
  22. Li, X.; Krumholz, H.M.; Yip, W.; Cheng, K.K.; De Maeseneer, J.; Meng, Q.; Mossialos, E.; Li, C.; Lu, J.; Su, M.; et al. Quality of primary health care in China: Challenges and recommendations. Lancet 2020, 395, 1802–1812. [Google Scholar] [CrossRef] [PubMed]
  23. Institute of Medicine (US) Committee on Health Literacy. In Health Literacy: A Prescription to End Confusion; Nielsen-Bohlman, L.; Panzer, A.M.; Kindig, D.A. (Eds.) National Academies Press (US): Washington, DC, USA, 2004. [Google Scholar]
  24. Zhang, L.; Liao, J.; Pan, X.; Liang, D.; Zeng, J.; Sun, M.; Luo, X.; Ma, X.; Yin, M.; Ni, J. How to make more people adopt healthy behaviors? Assessing health literacy, health promoting lifestyle and their association of community residents in Shenzhen, China. Front. Public Health 2022, 10, 900883. [Google Scholar] [CrossRef] [PubMed]
  25. Zhou, Y.; Tang, J.; Zhang, J.; Wu, Q. Impact of the coronavirus disease 2019 epidemic and a free influenza vaccine strategy on the willingness of residents to receive influenza vaccines in Shanghai, China. Hum. Vaccin. Immunother. 2021, 17, 2289–2292. [Google Scholar] [CrossRef] [PubMed]
  26. You, Y.; Li, X.; Jiang, S.; Liang, J.; Xie, P.; Zou, X.; Liu, G.; Han, X. Can primary care physician recommendation improve influenza vaccine uptake among older adults? A community health centre-based experimental study in China. BMC Prim. Care 2023, 24, 16. [Google Scholar] [CrossRef] [PubMed]
  27. Nagata, J.M.; Hernández-Ramos, I.; Kurup, A.S.; Albrecht, D.; Vivas-Torrealba, C.; Franco-Paredes, C. Social determinants of health and seasonal influenza vaccination in adults ≥65 years: A systematic review of qualitative and quantitative data. BMC Public Health 2013, 13, 388. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Kwong, E.W.; Lam, I.O.; Chan, T.M. What factors affect influenza vaccine uptake among community-dwelling older Chinese people in Hong Kong general outpatient clinics? J. Clin. Nurs. 2009, 18, 960–971. [Google Scholar] [CrossRef] [PubMed]
  29. Wang, J.; Jing, R.; Lai, X.; Zhang, H.; Lyu, Y.; Knoll, M.D.; Fang, H. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines 2020, 8, 482. [Google Scholar] [CrossRef] [PubMed]
  30. China National Influenza Center. Summary of Influenza Epidemic in China (8th Weekly Report). Available online: https://ivdc.chinacdc.cn/cnic/zyzx/lgzb/202303/t20230302_264010.htm (accessed on 6 March 2023).
  31. McAnerney, J.M.; Walaza, S.; Cohen, A.L.; Tempia, S.; Buys, A.; Venter, M.; Blumberg, L.; Duque, J.; Cohen, C. Effectiveness and knowledge, attitudes and practices of seasonal influenza vaccine in primary healthcare settings in South Africa, 2010–2013. Influenza Other Respir. Viruses 2015, 9, 143–150. [Google Scholar] [CrossRef] [PubMed]
  32. Lytle, K.L.; Collins, S.P.; Feldstein, L.R.; Baughman, A.H.; Brown, S.M.; Casey, J.D.; Erickson, H.L.; Exline, M.C.; Files, D.C.; Gibbs, K.W.; et al. Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019–2020. Vaccine 2021, 39, 5271–5276. [Google Scholar] [CrossRef] [PubMed]
  33. National Bureau of Statistics of China. Statistical Bulletin of the People’s Republic of China on National Economic and Social Development in 2021. Available online: http://www.stats.gov.cn/tjsj/zxfb/202202/t20220227_1827960.html (accessed on 19 January 2023).
  34. Shenzhen Bureau of Statistics. Interpretation of the Main Data of the Seventh National Population Census of Shenzhen. Available online: http://tjj.sz.gov.cn/ztzl/zt/szsdqcqgrkpc/szrp/content/post_9138049.html (accessed on 6 March 2023).
Table 1. Characteristics of study participants in Shenzhen, September 2021 (N = 975).
Table 1. Characteristics of study participants in Shenzhen, September 2021 (N = 975).
CharacteristicsNPercentage (%)
Sex
Female54956.3
Male42643.7
Age (yrs)
60–6423023.6
65–7557559.0
Above 7517017.4
Marital status
Unmarried15215.6
Married82387.4
Education level
Primary school and below33834.7
Middle and high school50351.6
College and above13413.7
Monthly income (Chinese Yuan, CNY)
Low (1000 and below)26627.3
Middle (1001–5000)42944.0
High (5001 and above)28028.7
Self-reported health status
Well59260.7
General31632.4
Worse676.9
Chronic medical conditions
Yes44145.2
No53454.8
Ever received COVID-19 vaccine uptakes
Yes81383.4
No16216.6
Table 2. Knowledge of the influenza virus and vaccine among older adults in Shenzhen (N = 975).
Table 2. Knowledge of the influenza virus and vaccine among older adults in Shenzhen (N = 975).
ItemsNPercentage (%)
Influenza virus
Q1. What are influenza’s symptoms?
Acute fever (up to 39–40 Celsius degree)61162.7
Vomit, diarrhea25125.7
Sore joints, fatigue, decreasing appetite42643.7
Runny nose, stuffy nose, sneezing81183.2
Serious comorbidity will occur in severe cases21422.0
Q2. What is the approach to protecting against influenza?
Vaccination71773.5
Good hygiene66668.3
Enhance physical fitness and immunity65567.2
Minimize activities in crowded places46147.3
If you have respiratory infection symptoms, you should rest at home and seek medical treatment as soon as possible47348.5
Influenza vaccine
a Q3. Who are the priority populations that need to take influenza vaccination?
Healthcare workers69471.2
Vulnerable groups and employees67068.7
People in key places42443.5
Risky populations73775.6
Caregivers of infants26627.3
Pregnant women12813.1
b Q4. Do you know how the influenza vaccination frequency is scheduled?
Once a year62664.2
Every 5 years34935.8
Have no idea
c Q5. Do you know when to get the influenza vaccine?
In autumn and winter 56958.4
All year round40641.6
Have no idea
d Q6. How long does the flu vaccine protect after a single dose?
6–8 months42443.5
At least 5 years55156.5
Have no idea
Q7. Do you know where you can get the flu vaccine for seniors?
Yes72274.1
No25325.9
Q8. Have you ever heard about influenza vaccination for older adults?
Yes75977.9
No21622.1
Q9. Do you know the policy that older adults aged 60 years and above with Shenzhen household registration could have free influenza vaccination in Shenzhen?
Yes73875.7
No23724.3
a The details of answers for “Q3. Who are the prioritypopulations that need to take influenza vaccination?” are shown below: healthcare workers, including clinicians, public health staff, and health and quarantine staff; vulnerable groups and employees include people in places where people gather, such as elderly care institutions, long-term care institutions, and welfare homes; people in key places include nursery institutions, primary and secondary schools, and prison institutions; risky populations include older people aged 60 and above, children aged 6 months to 5 years, and patients with specific chronic diseases; infants’ caregivers include family members and caregivers of infants aged under 6 months; pregnant women include women who are pregnant or planning to become pregnant during flu season. b “Once a year” is the correct answer for Q4. c “In autumn and winter” is the correct answer for Q5. d “6–8 months” is the correct answer for Q6.
Table 3. Knowledge of the influenza virus and vaccine in the age, education, and income group analysis (N = 975) in Shenzhen, China f.
Table 3. Knowledge of the influenza virus and vaccine in the age, education, and income group analysis (N = 975) in Shenzhen, China f.
Items Age (Yrs)a p ValueEducation Levela p ValueIncome Levela p Value
60–64 (N = 230)65–75 (N = 575)Above 75 (N = 170)Primary and Below (N = 338)Middle and High School (N = 503)College and Above (N = 134)Low (N = 266)Middle (N = 429)High (N = 280)
Influenza virus
Q1. What are influenza’s symptoms?
Acute fever 142 (23.2)361 (59.1)108 (17.7)0.931192 (31.4)323 (52.9)96 (15.7)0.006146 (23.9)268 (43.9)197 (32.2)0.001
Vomit, diarrhea59 (23.5)152 (60.6)40 (15.9)0.74869 (27.5)139 (55.4)43 (17.1)0.01251 (20.3)102 (40.6)98 (39.0)<0.001
Sore joints, fatigue, decreasing appetite108 (25.4)251 (58.9)67 (15.7)0.323143 (33.6)217 (50.9)66 (15.5)0.366111 (26.1)168 (39.4)147 (34.5)0.002
Runny nose, stuffy nose, sneezing195 (24)472 (58.2)144 (17.8)0.550297 (36.6)410 (50.6)104 (12.8)0.010225 (27.7)357 (44.0)229 (28.2)0.682
Serious comorbidity 43 (20.1)131 (61.2)40 (18.7)0.38653 (24.8)114 (53.3)47 (22)<0.00143 (20.1)85 (39.7)86 (40.2)<0.001
Q2. What is the approach to protecting against influenza?
Vaccination151 (21.1)431 (60.1)135 (18.8)0.004234 (32.6)374 (52.2)109 (15.2)0.022165 (23.0)310 (43.2)242 (33.8)<0.001
Good hygiene157 (23.6)400 (60.1)109 (16.4)0.407213 (32)355 (53.3)98 (14.7)0.030151 (22.7)297 (44.6)218 (32.7)<0.001
Enhance physical fitness and immunity145 (22.1)393 (60)117 (17.9)0.309218 (33.3)336 (51.3)101 (15.4)0.074156 (23.8)280 (42.7)219 (33.4)<0.001
Minimize activities in crowded places102 (22.1)274 (59.4)85 (18.4)0.514148 (32.1)238 (51.6)75 (16.3)0.05798 (21.3)196 (42.5)167 (36.2)<0.001
Rest at home and seek medical treatment113 (23.9)278 (58.8)82 (17.3)0.977157 (33.2)247 (52.2)69 (14.6)0.570110 (23.3)202 (42.7)161 (34.0)0.001
Influenza vaccine
b Q3. Who are the priority populations that need to take influenza vaccination?
Healthcare workers152 (21.9)417 (60.1)125 (18)0.144216 (31.1)366 (52.7)112 (16.1)<0.001150 (21.6)300 (43.2)244 (35.2)<0.001
Vulnerable groups and employees153 (22.8)390 (58.2)127 (19)0.168220 (32.8)346 (51.6)104 (15.5)0.030160 (23.9)280 (41.8)230 (34.3)<0.001
People in key places93 (21.9)251 (59.2)80 (18.9)0.415120 (28.3)234 (55.2)70 (16.5)0.00190 (21.2)185 (43.6)149 (35.1)<0.001
Risky populations169 (22.9)439 (59.6)129 (17.5)0.690265 (36)374 (50.7)98 (13.3)0.316192 (26.1)326 (44.2)219 (29.7)0.252
Infants’ caregivers64 (24.1)148 (55.6)54 (20.3)0.29485 (32)133 (50)48 (18)0.05363 (23.7)113 (42.5)90 (33.8)0.072
Pregnant women29 (22.7)68 (53.1)31 (24.2)0.09134 (26.6)67 (52.3)27 (21.1)0.01428 (21.9)50 (39.1)50 (39.1)0.019
c Q4. Do you know how the influenza vaccination frequency is scheduled?
Once a year140 (22.4)380 (60.7)106 (16.9)0.324181 (28.9)346 (55.3)99 (15.8)<0.001140 (22.4)259 (41.4)227 (36.3)<0.001
Every 5 years90 (25.8)195 (55.9)64 (18.3) 157 (45.0)157 (45.0)35 (10.0) 126 (36.1)170 (48.7)53 (15.2)
Have no idea
d Q5. Do you know when to get the influenza vaccine?
In autumn and winter 129 (22.7)344 (60.5)96 (16.9)0.536162 (28.5)308 (54.1)99 (17.4)<0.001122 (21.4)244 (42.9)203 (35.7)<0.001
All year round101 (24.9)231 (56.9)74 (18.2) 176 (43.3)195 (48.0)35 (8.6) 144 (35.5)185 (45.6)77 (19.0)
Have no idea
e Q6. How long does the flu vaccine protect after a single dose?
6–8 months82 (19.3)267 (63)75 (17.7)0.020106 (25)231 (54.5)87 (20.5)<0.00174 (17.5)182 (42.9)168 (39.6)<0.001
At least 5 years148 (26.9)308 (55.9)95 (17.2) 232 (42.1)272 (49.4)47 (8.5) 192 (34.8)247 (44.8)112 (20.3)
Have no idea
Q7. Do you know the places where you can get the flu vaccine for seniors?
Yes154 (21.3)449 (62.2)119 (16.5)0.002225 (31.2)387 (53.6)110 (15.2)<0.001156 (21.6)321 (44.5)245 (33.9)<0.001
No76 (30.0)126 (49.8)51 (20.2) 113 (44.7)116 (45.8)24 (9.5) 110 (43.5)108 (42.7)35 (13.8)
Q8. Have you ever heard about influenza vaccination for older adults?
Yes167 (22)458 (60.3)134 (17.7)0.089238 (31.4)400 (52.7)121 (15.9)<0.001160 (21.1)344 (45.3)255 (33.6)<0.001
No63 (29.2)117 (54.2)36 (16.7) 100 (46.3)103 (47.7)13 (6.0) 106 (49.1)85 (39.4)25 (11.6)
Q9. Do you know the policy that older adults aged 60 years and above with Shenzhen household registration could have free influenza vaccination in Shenzhen?
Yes163 (22.1)449 (60.8)126 (17.1)0.085230 (31.2)392 (53.1)116 (15.7)<0.001155 (21)332 (45)251 (34)<0.001
No67 (28.3)126 (53.2)44 (18.6) 108 (45.6)111 (46.8)18 (7.6) 111 (46.8)97 (40.9)29 (12.2)
a p value is calculated from a Chi-square test. b The details of answers for “Q3. Who are the priority populations that need to take influenza vaccination?” are shown below: healthcare workers, including clinicians, public health staff, and health and quarantine staff; vulnerable groups and employees include people in places where people gather, such as elderly care institutions, long-term care institutions, and welfare homes; people in key places include nursery institutions, primary and secondary schools, and prison institutions; risky populations include older people aged 60 and above, children aged 6 months to 5 years, and patients with specific chronic diseases; infants’ caregivers include family members and caregivers of infants aged under 6 months; pregnant women include women who are pregnant or planning to become pregnant during flu season. c “Once a year” is the correct answer for Q4. d “In autumn and winter” is the correct answer for Q5. e “6–8 months” is the correct answer for Q6. f The number inside of brackets indicates percentages and outside of brackets indicates frequency.
Table 4. Attitudes towards the influenza vaccination and education program among older adults (N = 975) in Shenzhen, China.
Table 4. Attitudes towards the influenza vaccination and education program among older adults (N = 975) in Shenzhen, China.
ItemsNPercentage (%)
Q1. Do you think older adults should take influenza vaccination?
Yes86188.3
No11411.7
Q2. Do you think older adults with chronic medical conditions should take influenza vaccination?
Yes55057.1
No42543.6
Q3. Do you think participating in a health education program is beneficial for you to learn knowledge about vaccination?
Yes65266.9
No 32333.1
Table 5. Attitudes towards the influenza vaccine and education program in the age, education, and income group analysis (N = 975) in Shenzhen, China b.
Table 5. Attitudes towards the influenza vaccine and education program in the age, education, and income group analysis (N = 975) in Shenzhen, China b.
Items Age (Yrs)a p ValueEducation Levela p ValueIncome Levela p Value
60~64 (N = 230)65~75 (N = 575)Above 75 (N = 170)Primary and Below (N = 338)Middle and High School (N = 503)College and Above (N = 134)Low (N = 266)Middle (N = 429)High (N = 280)
Q1. Do you think older adults should take influenza vaccination?
No28 (24.6)64 (56.1)22 (19.3)0.78553 (46.5)51 (44.7)10 (8.8)0.01352 (45.6)45 (39.5)17 (14.9)<0.001
Yes202 (23.5)511 (59.3)148 (17.2) 285 (33.1)452 (52.5)124 (14.4) 214 (24.9)384 (44.6)263 (30.5)
Q2. Do you think older adults with chronic medical conditions should take influenza vaccination?
No115 (27.1)251 (59.1)59 (13.9)0.010172 (40.5)211 (49.6)42 (9.9)<0.001140 (32.9)195 (45.9)90 (21.2)<0.001
Yes115 (20.9)324 (58.9)111 (20.2) 166 (30.2)292 (53.1)92 (16.7) 126 (22.9)234 (42.5)190 (34.5)
Q3. Do you think participating in a health education program is beneficial for you to learn knowledge about vaccination?
No74 (22.9)186 (57.6)63 (19.5)0.487137 (42.4)160 (49.5)26 (8)<0.001134 (41.5)128 (39.6)61 (18.9)<0.001
Yes156 (23.9)389 (59.7)107 (16.4) 201 (30.8)343 (52.6)108 (16.6) 132 (20.2)301 (46.2)219 (33.6)
a p value is calculated from a Chi-square test. b The number inside of brackets indicates percentages and outside of brackets indicates frequency.
Table 6. Practices of the influenza vaccination among older adults (N = 975) in Shenzhen, China.
Table 6. Practices of the influenza vaccination among older adults (N = 975) in Shenzhen, China.
ItemsNPercentage (%)
Cues to actions
Q1. Did community health workers recommend the influenza vaccination to you?
Yes65367.0
No32233.0
Q2. Are there any older adults around you who had influenza vaccination?
Yes58059.5
No39540.5
Q3. Ever participated in a health education activity?
Yes33334.2
No64265.8
Actions
Q4. Have you ever received influenza vaccination?
No, never received43344.4
Yes, ever received54255.6
Q5. Have you received influenza vaccination in 2020?
No 52153.4
Yes45446.6
Q6. Reasons for being unwilling or unsure to receive the influenza vaccines
Stay at a good condition, no need to take vaccine11927.5
Do not know about vaccination18643.0
Influenza vaccine is not safe enough286.4
Influenza vaccine has no effect122.8
Have no time to take vaccine5412.5
Influenza is not important and will not lead to any serious results306.9
It is inconvenient to go to the vaccination places4510.4
The cost of vaccination is too much235.3
Physicians do not recommend it245.5
Others5212.0
Table 7. Practices towards the influenza vaccine in the age, education, and income group analysis (N = 975) in Shenzhen, China b.
Table 7. Practices towards the influenza vaccine in the age, education, and income group analysis (N = 975) in Shenzhen, China b.
Items Age (Yrs)a p ValueEducation Levela p ValueIncome Levela p Value
60–64 (N = 230)65–75 (N = 575)Above 75 (N = 170)Primary and Below (N = 338)Middle and High School (N = 503)College and Above (N = 134)Low (N = 266)Middle (N = 429)High (N = 280)
Q1. Did community health workers recommend the influenza vaccination to you?
No87 (27.0)180 (55.9)55 (17.1)0.202140 (43.5)156 (48.4)26 (8.1)<0.001130 (40.4)137 (42.5)55 (17.1)<0.001
Yes143 (21.9)395 (60.5)115 (17.6) 198 (30.3)347 (53.1)108 (16.5) 136 (20.8)292 (44.7)225 (34.5)
Q2. Are there any older adults around you who had influenza vaccination?
No115 (29.1)212 (53.7)68 (17.2)0.003163 (41.3)192 (48.6)40 (10.1)<0.001150 (38.0)171 (43.3)74 (18.7)<0.001
Yes115 (19.8)363 (62.6)102 (17.6) 175 (30.2)311 (53.6)94 (16.2) 116 (20.0)258 (44.5)206 (35.5)
Q3. Ever participated in a health education activity?
No161 (25.1)364 (56.7)117 (18.2)0.130254 (39.6)306 (47.7)82 (12.8)<0.001217 (33.8)265 (41.3)160 (24.9)<0.001
Yes69 (20.7)211 (63.4)53 (15.9) 84 (25.2)197 (59.2)52 (15.6) 49 (14.7)164 (49.2)120 (36.0)
Q4. Have you ever received influenza vaccination?
No130 (30.0)238 (55.0)65 (15.0)<0.001186 (43.0)209 (48.3)38 (8.8)<0.001166 (38.3)200 (46.2)67 (15.5)<0.001
Yes100 (18.5)337 (62.2)105 (19.4) 152 (28.0)294 (54.2)96 (17.7) 100 (18.5)229 (42.3)213 (39.3)
Q5. Have you received influenza vaccination in 2020?
No142 (27.3)298 (57.2)81 (15.5)0.010212 (40.7)252 (48.4)57 (10.9)<0.001179 (34.4)235 (45.1)107 (20.5)<0.001
Yes88 (19.4)277 (61.0)89 (19.6) 126 (27.8)251 (55.3)77 (17.0) 87 (19.2)194 (42.7)173 (38.1)
a p value is calculated from a Chi-square test. b The number inside of brackets indicates percentages and outside of brackets indicates frequency.
Table 8. Multivariate regression analysis of the associated factors of covariates on the previous actions of influenza vaccination and actions.
Table 8. Multivariate regression analysis of the associated factors of covariates on the previous actions of influenza vaccination and actions.
FactorsActions of VaccinationActions of Vaccination in 2020
Never Received N (%)Ever Received N (%)a p ValueOR (95% CI)Not Received N (%)Received N (%)p ValueOR (95% CI)
Sex
Female239 (43.5)310 (56.5)0.532 290 (52.8)259 (47.2)0.663
Male194 (45.5)232 (54.5) 231 (54.2)195 (45.8)
Age (yrs)
60–64130 (56.5)100 (43.5)<0.001ref142 (61.7)88 (38.3)0.010ref
65–75238 (41.4)337 (58.6) 1.46 (1.01, 2.10)298 (51.8)277 (48.2) 1.18 (0.83, 1.68)
Above 7565 (38.2)105 (61.8) 1.81 (1.10, 2.98)81 (47.6)89 (52.4) 1.80 (1.11, 2.92)
Marital status
Unmarried86 (56.6)66 (43.4)0.001ref103 (67.8)49 (32.2)<0.001ref
Married347 (42.2)476 (57.8) 1.18 (0.77, 1.84)418 (50.8)405 (49.2) 1.54 (0.99, 2.36)
Education level
Primary school and below186 (55.0)152 (45.0)<0.001ref212 (62.7)126 (37.3)<0.001ref
Middle and high school209 (41.6)294 (58.4) 1.12 (0.79, 1.60)252 (50.1)251 (49.9) 1.14 (0.81, 1.60)
College and above38 (28.4)96 (71.6) 1.12 (0.64, 1.96)57 (42.5)77 (57.5) 0.94 (0.57, 1.56)
Monthly income (CNY)
Low (1000 and below)166 (62.4)100 (37.6)<0.001ref179 (67.3)87 (32.7)<0.001ref
Middle (1001–5000)200 (46.6)229 (53.4) 1.32 (0.90, 1.92)235 (54.8)194 (45.2) 1.19 (0.82, 1.73)
High (5001 and above)67 (23.9)213 (76.1) 2.64 (1.66, 4.18)107 (38.2)173 (61.8) 1.69 (1.10, 2.61)
Self-reported health status
Well265 (44.8)327 (55.2)0.442 306 (51.7)286 (48.3)0.197
General134 (42.4)182 (57.6) 173 (54.7)143 (45.3)
Worse34 (50.7)33 (49.3) 42 (62.7)25 (37.3)
Chronic medical conditions
No223 (41.8)311 (58.2)0.067 240 (54.4)201 (45.6)0.575
Yes210 (47.6)231 (52.4) 281 (52.6)253 (47.4)
Received COVID-19 vaccine uptakes
No83 (51.2)79 (48.8)0.056 106 (65.4)56 (34.6)0.001ref
Yes350 (43.1)463 (56.9) 415 (51.0)398 (49.0) 1.57 (1.05, 2.37)
How long does the flu vaccine protect after a single dose?
At least 5 years336 (61.0)215 (39.0)<0.001ref372 (67.5)179 (32.5)<0.001ref
Have no idea
6–8 months97 (22.9)327 (77.1) 2.76 (1.99, 3.84)149 (35.1)275 (64.9) 2.15 (1.58, 2.93)
Do you know where you can get the flu vaccine for seniors?
No203 (80.2)50 (19.8)<0.001ref309 (42.8)413 (57.2)<0.001ref
Yes230 (31.9)492 (68.1) 5.00 (3.42, 7.32)212 (82.8)41 (16.2) 4.22 (2.85, 6.24)
Do you think older adults with chronic medical conditions should take influenza vaccination?
No267 (62.8)158 (37.2)<0.001ref294 (69.2)131 (30.8)<0.001ref
Yes166 (30.2)384 (69.8) 2.08 (1.51, 2.85)227 (41.3)323 (58.7) 1.73 (1.27, 2.35)
a p value is calculated from multivariable regression analysis.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

You, Y.; Li, X.; Chen, B.; Zou, X.; Liu, G.; Han, X. Knowledge, Attitude, and Practice towards Influenza Vaccination among Older Adults in Southern China during the COVID-19 Pandemic. Vaccines 2023, 11, 1197. https://doi.org/10.3390/vaccines11071197

AMA Style

You Y, Li X, Chen B, Zou X, Liu G, Han X. Knowledge, Attitude, and Practice towards Influenza Vaccination among Older Adults in Southern China during the COVID-19 Pandemic. Vaccines. 2023; 11(7):1197. https://doi.org/10.3390/vaccines11071197

Chicago/Turabian Style

You, Yating, Xiaoheng Li, Binglin Chen, Xuan Zou, Gang Liu, and Xinxin Han. 2023. "Knowledge, Attitude, and Practice towards Influenza Vaccination among Older Adults in Southern China during the COVID-19 Pandemic" Vaccines 11, no. 7: 1197. https://doi.org/10.3390/vaccines11071197

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop